
0.3976 Delayed Data As of Mar 24 | ![]() Today’s Change | 0.35 Today|||52-Week Range 2.77 | -66.31% Year-to-Date |
Biotech Stock Roundup: ACAD's Drug Approval, SGEN to be Acquired by PFE & More Mar 16 / Zacks.com - Paid Partner Content | Aridis (ARDS) Stock Up as Cystic Fibrosis Study Meets Goals Mar 14 / Zacks.com - Paid Partner Content |
Previous close | 0.41 |
Today’s open | 0.41 |
Day’s range | 0.39 - 0.41 |
Volume | 908 |
Average volume (3 months) | 1,122,350 |
Market cap | $14.4M |
Earnings growth (last year) | -54.71% |
Earnings growth (this year) | +54.89% |
Earnings growth (next 5 years) | +51.90% |
Revenue growth (last year) | +53.50% |
P/E ratio | NM |
Price/Sales | 18.66 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
CEMIChembio Diagnostics ... | -0.00 | -0.26% |
NNVCNanoViricides Inc | -0.05 | -3.82% |
TPSTTempest Therapeutics... | 0.00 | 0.00% |
CLRBCellectar Bioscience... | -0.06 | -3.90% |
Next reporting date | March 30, 2023 |
EPS forecast (this quarter) | -$0.41 |
Annual revenue (last year) | $1.5M |
Annual profit (last year) | -$42.2M |
Net profit margin | -2,748.73% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Los Gatos, California |